{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-025960","form_type":"8-K","ticker":"IDXG","cik":"0001054102","company_name":"INTERPACE BIOSCIENCES, INC.","filed_at":"2025-12-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.675520+00:00","generated_at":"2026-05-16T15:00:30.843711+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Interpace Biosciences fully repays BroadOak term loan early, strengthens balance sheet","bullets":["Fully repaid outstanding term loan facility with BroadOak Capital Partners prior to maturity.","Original Loan and Security Agreement dated October 29, 2021 with BroadOak Fund V, L.P.","Early repayment eliminates related interest expenses, increasing operational flexibility.","CFO Chris McCarthy says repayment reflects robust financial performance and disciplined capital management.","Company now focused on driving commercial growth and record testing volumes/revenue for thyroid tests."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-025960","json":"https://secwatch.observer/filing/0001493152-25-025960.json","markdown":"https://secwatch.observer/filing/0001493152-25-025960.md","text":"https://secwatch.observer/filing/0001493152-25-025960.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1054102/000149315225025960/0001493152-25-025960-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1054102/000149315225025960/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T15:00:30.843711+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}